The necessity for intra-action reviews during the COVID-19 pandemic
- PMID: 33038949
- PMCID: PMC7544463
- DOI: 10.1016/S2214-109X(20)30414-9
The necessity for intra-action reviews during the COVID-19 pandemic
Comment in
-
COVID-19 intra-action reviews: potential for a sustained response plan.Lancet Glob Health. 2021 May;9(5):e594. doi: 10.1016/S2214-109X(21)00078-4. Epub 2021 Mar 2. Lancet Glob Health. 2021. PMID: 33667403 Free PMC article. No abstract available.
References
-
- WHO Prioritizing diseases for research and development in emergency contexts. https://www.who.int/activities/prioritizing-diseases-for-research-and-de...
-
- WHO WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/
-
- WHO Guidance for after action review (AAR) 2019. https://www.who.int/ihr/publications/WHO-WHE-CPI-2019.4/en/
-
- WHO Critical preparedness, readiness and response actions for COVID-19. June 24, 2020. https://apps.who.int/iris/handle/10665/332665
-
- WHO Guidance for conducting a country COVID-19 intra-action review (IAR) July 23, 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-Country_IAR-2020.1
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical